Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mathilde Gotanègre"'
Autor:
Pierre-Luc Mouchel, Laure David, Jean-Emmanuel Sarry, Véronique Mansat-De Mas, Sarah Bertoli, Maëlle Cartel, Mathilde Gotanègre, Stéphane Manenti, Arnaud Besson, Christine Didier
Publikováno v:
Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2021, 35, pp.417-432. ⟨10.1038/s41375-020-0878-x⟩
Leukemia, 2021, 35, pp.417-432. ⟨10.1038/s41375-020-0878-x⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2021, 35, pp.417-432. ⟨10.1038/s41375-020-0878-x⟩
Leukemia, 2021, 35, pp.417-432. ⟨10.1038/s41375-020-0878-x⟩
International audience; Resistance of acute myeloid leukemia (AML) to therapeutic agents is frequent. Consequently, the mechanisms leading tothis resistance must be understood and addressed. In this paper, we demonstrate that inhibition of deubiquiti
Autor:
Lara Gales, Camille Montersino, Marc Conti, Pierre Bories, Courtney D. DiNardo, Brandon Nicolay, Fabien Jourdan, Nicolas Broin, Mohsen Hosseini, Guillaume Cognet, Yves Gibon, Marie Sabatier, Tony Kaoma, Marina Konopleva, Lucille Stuani, Mathilde Gotanègre, Christian Recher, Laurent Fernando, Vera Pancaldi, Nathalie Poupin, Estelle Saland, Jean-Emmanuel Sarry, Joseph R. Marszalek, Andrei Turtoi, Thomas Farge, Feng Wang, Yves Collette, Laurent Le Cam, Madi Y. Cissé, Cédric Cassan, Alexis Hucteau, Claudie Bosc, Natalia Baran, Sebastien Ronseaux, Aliki Zavoriti, François Fenaille, Florence Castelli, Laetitia K. Linares, Evgenia Turtoi, Emeline Chu-Van, Martin Carroll, Pierre-Luc Mouchel, Mary A. Selak, Guillaume Cazals, Emeline Boet, Rémy Castellano, Floriant Bellvert, Norbert Vey, Clément Larrue, Koichi Takahashi, Ambrine Sahal, Sylvain Loric, Jean-Charles Portais
Publikováno v:
Journal of Experimental Medicine
Journal of Experimental Medicine, 2021, 218 (5), pp.e20200924. ⟨10.1084/jem.20200924⟩
Journal of Experimental Medicine, Rockefeller University Press, 2021, 218 (5), ⟨10.1084/jem.20200924⟩
The Journal of Experimental Medicine
Journal of Experimental Medicine, 2021, 218 (5), pp.e20200924. ⟨10.1084/jem.20200924⟩
Journal of Experimental Medicine, Rockefeller University Press, 2021, 218 (5), ⟨10.1084/jem.20200924⟩
The Journal of Experimental Medicine
Stuani et al. demonstrate that IDH mutant AML cells display an enhanced mitochondrial phenotype, which is not reversed by IDH mutant inhibitors. This study provides a scientific rationale for combinatory mitochondrial-targeted therapies to treat IDH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dfb2b30f8b948c067d643d1119fbb0e
https://amu.hal.science/hal-03563454/file/jStuani_em_20200924.pdf
https://amu.hal.science/hal-03563454/file/jStuani_em_20200924.pdf
Autor:
Claudie Bosc, Jean-Emmanuel Sarry, Marc Piechaczyk, Thomas Farge, Sonia Zaghdoudi, Mohsen Hosseini, Hamid Reza Rezvani, Véronique Guyonnet-Duperat, Clément Larrue, Mathilde Gotanègre, Nesrine Aroua, Pierre Luc Mouchel, Latifa Jarrou, Marie Sabatier, Christian Recher, Guillaume Bossis, Estelle Saland
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2019, 79 (20), pp.5191-5203. ⟨10.1158/0008-5472.CAN-19-0515⟩
Cancer Research, American Association for Cancer Research, 2019, 79 (20), pp.5191-5203. ⟨10.1158/0008-5472.CAN-19-0515⟩
Chemotherapies alter cellular redox balance and reactive oxygen species (ROS) content. Recent studies have reported that chemoresistant cells have an increased oxidative state in hematologic malignancies. In this study, we demonstrated that chemoresi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc41bc9f60c1650a8b74e7e7404e62da
https://hal.umontpellier.fr/hal-02394533
https://hal.umontpellier.fr/hal-02394533